Notably, the reduction of SDF1 level in CAFs through siSDF1 or the inhibition of CXCR4 through siCXCR4 or antibodies leads to a downregulation of AGR2 expression, which suppresses the growth and metastatic potential of PNET cells. The gene discussed is AGR2; the disease is primitive neuroectodermal tumor.